Precision BioSciences, Inc. (DTIL)

Precision BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	62.24	85.9	116.68	189.58	143.66	89.8
Short-Term Investments	-	0.41	-	-	-	-
Cash & Short-Term Investments	62.24	86.31	116.68	189.58	143.66	89.8
Cash Growth	-49.63%	-26.02%	-38.45%	31.96%	59.98%	-50.36%
Accounts Receivable	-	1.7	0.9	0.72	0.49	10
Receivables	-	1.7	12.8	0.72	0.49	10
Prepaid Expenses	7.45	6.44	5.98	6.03	17.43	5.76
Other Current Assets	0.57	0.54	0.91	2.78	0.17	0
Total Current Assets	70.26	94.99	136.36	199.11	161.75	105.56
Property, Plant & Equipment	8.82	10.18	14.6	13.78	29.33	41.5
Long-Term Investments	0.74	3.21	3.21	4.75	6.84	-
Other Intangible Assets	0.61	0.62	0.4	0.73	2.05	1.37
Other Long-Term Assets	22.77	22.79	0.23	12.57	4.64	1.72
Total Assets	108.93	136.39	159.78	238.17	211.5	150.16
Accounts Payable	1.12	1.31	2.97	0.65	1.14	0.79
Accrued Expenses	3.44	7.2	6.54	6.93	10.79	9.01
Short-Term Debt	-	-	22.41	-	-	-
Current Portion of Leases	1.41	1.32	1.13	1.68	1.82	1.93
Current Unearned Revenue	5.99	2.96	12.04	46.19	21.24	30.24
Other Current Liabilities	1.61	2.19	4.9	4.21	0.98	0.85
Total Current Liabilities	13.57	14.98	49.99	59.66	35.98	42.83
Long-Term Debt	22.35	22.32	-	22.22	2.48	-
Long-Term Leases	5.68	6.4	7.72	1.06	4.81	8.59
Long-Term Unearned Revenue	30.23	33.3	83.08	92.87	77.02	53.93
Other Long-Term Liabilities	3.05	2.99	0.13	1.92	0.04	0.39
Total Liabilities	74.87	80	140.92	177.74	120.33	105.73
Common Stock	0	0	0	0	-	-
Additional Paid-In Capital	561.55	539.81	509.44	489.7	408.8	331.45
Retained Earnings	-526.55	-482.46	-489.63	-428.31	-316.68	-286.07
Treasury Stock	-0.95	-0.95	-0.95	-0.95	-0.95	-0.95
Total Common Equity	34.05	56.39	18.86	60.43	91.17	44.43
Shareholders' Equity	34.05	56.39	18.86	60.43	91.17	44.43
Total Liabilities & Equity	108.93	136.39	159.78	238.17	211.5	150.16
Total Debt	29.45	30.05	31.27	24.96	9.11	10.52
Net Cash (Debt)	32.8	56.27	85.41	164.62	134.55	79.28
Net Cash Growth	-64.64%	-34.12%	-48.12%	22.35%	69.72%	-56.17%
Net Cash Per Share	3.68	8.17	22.23	56.19	68.78	45.71
Filing Date Shares Outstanding	11.79	10.48	6.92	3.71	2.03	1.9
Total Common Shares Outstanding	11.64	8.2	4.16	3.7	2.03	1.76
Working Capital	56.69	80.01	86.37	139.44	125.77	62.74
Book Value Per Share	2.93	6.87	4.53	16.34	44.91	25.29
Tangible Book Value	33.45	55.77	18.46	59.7	89.12	43.05
Tangible Book Value Per Share	2.87	6.80	4.43	16.14	43.90	24.51
Machinery	-	18.7	19.38	20.78	22.93	25.3
Construction In Progress	-	0.01	0.07	0.52	3.04	1.89
Leasehold Improvements	-	12.03	11.95	11.95	22.78	26.58

Updated Aug 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q